EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Four new mouse models of Duchenne muscular dystrophy with clinically relevant exon deletions in the human DMD gene

Maaike van Putten iD, Margot Linssen, Christa Tanganyika-de Winter, Conny M Brouwers iD, Jill W C Claassens iD, Nisha Verwey, Max Walsh, Tiberiu Loredan Stan, Annemieke Aartsma-Rus iD, Peter Hohenstein iD

Disease Models & Mechanisms · 2026

DOI: 10.1242/dmm.052875 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Disease Models & Mechanisms, 2026. Verfasst von Maaike van Putten und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands. Hauptthemen laut MEDLINE: Exons, Muscular Dystrophy, Duchenne, Dystrophin, Sequence Deletion. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AFM-Telethon, AFM-Téléthon, Leids Universitair Medisch Centrum.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Variant-specific therapeutic approaches, such as exon skipping or gene editing, hold promise for the treatment of Duchenne muscular dystrophy (DMD). Translatability of preclinical studies investigating these approaches could greatly be improved through the use of humanized mouse models, as these allow preclinical testing of human-specific sequences. We developed four novel humanized mouse models of DMD with a deletion of exon 44, 45, 51 or 53 in the human DMD gene, in a mouse dystrophin-negative background (mdx mouse; exon 23 nonsense mutation). Our optimized prescreening pipeline allowed us to do so very efficiently with the CRISPR-Cas9 technology. We confirmed either complete lack of dystrophin or expression of trace levels, which led to development of muscle pathology consisting of muscle fiber degeneration and regeneration, inflammation and fibrosis in young adult mice. Intramuscular treatment with vivo-morpholinos targeting a flanking exon induced exon skipping in the DMD strains, which restored the disrupted open reading frame and, subsequently, dystrophin expression. This validates these models as valuable tools for preclinical studies investigating human sequence-specific therapeutic approaches for DMD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExonsMuscular Dystrophy, DuchenneDystrophinSequence DeletionAnimalsHumansDisease Models, AnimalMiceMice, Inbred mdxCRISPR-Cas SystemsBase SequenceMuscle, SkeletalMaleMice, Inbred C57BLOligonucleotides, Antisense

Stichwörter der Autor:innen

Antisense oligonucleotideDuchenne muscular dystrophyExon skippingGenome editingMouse model

Substanzen

DystrophinDMD protein, humanOligonucleotides, Antisense

Autor:innen und Institutionen

  • Department of Human Genetics, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands.
  • Transgenic Facility Leiden, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands.

ORCID-Profile: Maaike van Putten, Conny M Brouwers, Jill W C Claassens, Annemieke Aartsma-Rus, Peter Hohenstein

Förderung

  • AFM-Telethon
  • AFM-Téléthon
  • Leids Universitair Medisch Centrum
  • REGENXBIO

Zitieren

APA

van Putten, M., Linssen, M., Tanganyika-de Winter, C., Brouwers, C. M., Claassens, J. W. C., Verwey, N., Walsh, M., Loredan Stan, T., Aartsma-Rus, A., & Hohenstein, P. (2026). Four new mouse models of Duchenne muscular dystrophy with clinically relevant exon deletions in the human DMD gene. Disease Models & Mechanisms. https://doi.org/10.1242/dmm.052875

Vancouver

van Putten M, Linssen M, Tanganyika-de Winter C, Brouwers CM, Claassens JWC, Verwey N, et al. Four new mouse models of Duchenne muscular dystrophy with clinically relevant exon deletions in the human DMD gene. Disease Models & Mechanisms. 2026. doi:10.1242/dmm.052875

BibTeX
@article{vanPutten2026,
  author = {van Putten, Maaike and Linssen, Margot and Tanganyika-de Winter, Christa and Brouwers, Conny M and Claassens, Jill W C and Verwey, Nisha and Walsh, Max and Loredan Stan, Tiberiu and Aartsma-Rus, Annemieke and Hohenstein, Peter},
  title = {Four new mouse models of Duchenne muscular dystrophy with clinically relevant exon deletions in the human DMD gene},
  journal = {Disease Models & Mechanisms},
  year = {2026},
  doi = {10.1242/dmm.052875}
}
Kostenlos starten →